Fate Therapeutics
FATE
A$1.87
Share price
0.83%
Change (1 day)
-63.55%
Change (1 year)
Categories
Stock price history for Fate Therapeutics (FATE)
Highest end of day price: A$181.02 AUD on 2021-01-14
Lowest end of day price: A$1.05 AUD on 2025-04-03
Stock price history of Fate Therapeutics from 2013 to 2025
Annual Stock Price Performance
| Year | Performance |
|---|---|
| 2025 | -26.67% |
| 2024 | -55.28% |
| 2023 | -63.23% |
| 2022 | -83.26% |
| 2021 | -34.76% |
| 2020 | 367.03% |
| 2019 | 44.64% |
| 2018 | 103.65% |
| 2017 | 127.14% |
| 2016 | -23.71% |
| 2015 | -34.44% |
| 2014 | -20.91% |
| 2013 | -5.14% |
Stock price for similar companies or competitors
| Company | Stock price | Change 1d% | Country |
|---|---|---|---|
 Sarepta Therapeutics
SRPT | A$32.03 | -3.66% | 🇺🇸 USA |
 Becton Dickinson BDX | A$259.95 | -0.79% | 🇺🇸 USA |
 PTC Therapeutics
PTCT | A$77.76 | -0.83% | 🇺🇸 USA |
 Avidity Biosciences RNA | A$45.21 | -0.14% | 🇺🇸 USA |
 Neurocrine Biosciences
NBIX | A$196.30 | 1.95% | 🇺🇸 USA |